Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 11 of 39

  1. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial

  2. Dexamethasone

    The First People's Hospital of Lianyungang

    Pancreatic Cancer

    approved small molecule active

    1 trial

  3. Dexamethasone and N-acetylcysteine (NAC)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  4. Dexamethasone and N-acetylcysteine (NAC)

    Hospital Authority, Hong Kong

    Carbon Monoxide Poisoning

    approved small molecule active

    1 trial

  5. Dexamethasone tablets for Solid tumors

    Disc Medicine

    Solid tumors

    approved small molecule active

    1 trial

  6. Dexlansoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    4 trials

  7. Dexlansoprazole 60 MG

    Takeda

    GERD

    approved small molecule completed

    1 trial

  8. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Breast Cancer

    approved small molecule completed

    1 trial

  9. Dexmedetomidine

    Peking University Third Hospital

    Breast Cancer

    approved small molecule completed

    1 trial

  10. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lower Limb Fracture

    approved small molecule completed

    1 trial

  11. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Post-Surgical Pain

    approved small molecule active

    1 trial

  12. Dexmedetomidine

    BioXcel Therapeutics

    Schizophrenia Agitation

    approved small molecule active

    1 trial

  13. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Older Patients

    approved small molecule active

    1 trial

  14. Dexmedetomidine

    Peking University Third Hospital

    Aged

    approved small molecule completed

    1 trial

  15. Dexmedetomidine

    The University of Hong Kong

    Anxiety, Separation

    approved small molecule active

    1 trial

  16. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Elderly

    approved small molecule completed

    3 trials

  17. Dexmedetomidine

    Hospital Authority, Hong Kong

    Thyroid Diseases

    approved small molecule active

    1 trial

  18. Dexmedetomidine

    United Therapeutics Europe Ltd

    Breast Cancer

    approved small molecule active

    1 trial

  19. Dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Thoracic Paravertebral Blocks

    approved small molecule terminated

    1 trial

  20. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule completed

    1 trial

  21. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Renal Function

    approved small molecule active

    1 trial

  22. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Delirium After Living Donor Renal Transplantation

    approved small molecule active

    1 trial

  23. Dexmedetomidine

    The First People's Hospital of Lianyungang

    Overall Survival

    approved small molecule completed

    1 trial

  24. Dexmedetomidine Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    approved small molecule completed

    1 trial

  25. Dexmedetomidine Injectable Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epilepsy

    approved small molecule completed

    1 trial

  26. Dexmedetomidine-esketamine combination

    The First People's Hospital of Lianyungang

    Obstructive Sleep Apnea

    approved small molecule active

    1 trial

  27. Dextrose 5%

    Hospital Authority, Hong Kong

    End-Stage Kidney Disease

    approved small molecule active

    1 trial

  28. Diane-35 pretreatment

    The First People's Hospital of Lianyungang

    Polycystic Ovary Syndrome

    approved small molecule active

    1 trial

  29. Digital Engagement Application (GD App)

    Takeda

    Gaucher Disease

    approved other completed

    1 trial

  30. Digoxin

    Teva Pharma GmbH

    Heart Failure

    approved small molecule completed

    1 trial

  31. Dimethyl fumarate

    Biogen

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  32. Donepezil

    Universal Integrated

    Total Knee Arthroplasty

    approved small molecule active

    1 trial

  33. Dotarem®

    Guerbet

    Primary Brain Tumor

    approved small molecule completed

    1 trial

  34. Double Blind Varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Vaping

    approved small molecule completed

    1 trial

  35. Double dose of PPI

    Takeda

    Dyspepsia

    approved small molecule completed

    1 trial

  36. Drawtex dressing

    United Therapeutics Europe Ltd

    Pilonidal Disease

    approved other active

    1 trial

  37. Dronabinol

    BRIGHT MINDS BIOSCIENCES INC.

    Pregnancy Related

    approved small molecule completed

    1 trial

  38. Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma

    approved small molecule active

    1 trial

  39. Drug: cimetidine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    approved small molecule completed

    1 trial

  40. Dual chamber pacemeker

    Rhythm Pharmaceuticals Netherlands B.V.

    Syncope

    approved other completed

    1 trial

  41. Dupilumab

    Sanofi Pasteur

    Asthma

    approved small molecule active

    2 trials

  42. Dupilumab

    Regeneron UK Limited

    Eosinophilic Oesophagitis

    approved small molecule active

    1 trial

  43. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis

    approved small molecule active

    16 trials

  44. Dupilumab

    Regeneron UK Limited

    Dermal Hypersensitivity Reaction

    approved small molecule completed

    1 trial

  45. Dupilumab

    Regeneron UK Limited

    Atopic Dermatitis (AD)

    approved small molecule terminated

    2 trials

  46. Dupilumab

    Regeneron UK Limited

    Eosinophilic Esophagitis

    approved small molecule active

    4 trials

  47. Dupilumab

    Regeneron UK Limited

    Allergic Contact Dermatitis

    approved small molecule active

    1 trial

  48. Dupilumab

    Regeneron UK Limited

    Eczema

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.